The market is there if they can get their act together:
https://kidney.org.au/nofilter/deloittereport?utm_source=newsletter&utm_medium=email+&utm_campaign=deloitte&_cldee=GvvQgnWdIAeRcZEaXJPHSK1Z6PoaDSXqoRFS8SklzVfnYz_lYDSsOCeLE6kH3xP0&recipientid=contact-be4d77e92348ec118c62002248159d41-bba68da9badb44a1a23f418dc71ea76d&esid=fabcb715-bbb0-ed11-83fe-00224818af37
The Report mentioned is by Deloitte.
I did have concern about the size of their target market quoted in their presentations as not all diabetics have kidney problems. But the test would be good for some as a diagnosis every few years. Once diagnised you would not complete another test. You would simply be tested on your GFR blood test to tell your kidney function.
Ann: PromarkerD application for Australian MBS to be resubmitted, page-38
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
82.0¢ |
Change
-0.050(5.75%) |
Mkt cap ! $107.9M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 86.0¢ | 79.5¢ | $179.2K | 217.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | 81.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.0¢ | 40020 | 2 |
View Market Depth
| Last trade - 11.58am 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
83.0¢ |
Change
-0.050 ( 4.52 %) |
||||
| Open | High | Low | Volume | ||
| 86.0¢ | 86.0¢ | 80.5¢ | 28984 | ||
| Last updated 11.29am 17/06/2024 ? | |||||
| PIQ (ASX) Chart |
